精密診断・医療市場：製品、技術、用途、エンドユーザー別-2025-2030年の世界予測

精密診断・医療市場は、2024年に1,602億1,000万米ドルと評価され、2025年には1,768億2,000万米ドル、CAGR 11.00%で成長し、2030年には2,997億1,000万米ドルに達すると予測されています。

精密診断・医療市場は、急速な技術革新、ヘルスケア需要の増大、個別化医療への広範なシフトに牽引され、かつてない変革期を迎えています。今日のダイナミックな環境では、診断精度と疾患の早期発見が効果的な治療戦略にとって極めて重要になっています。バイオテクノロジーやデータサイエンスから臨床イノベーションに至るまで、学際的な専門技術の融合が、疾患の発見と管理方法を再定義するブレークスルーの道を開いています。

本レポートでは、業界のリーダー、投資家、意思決定者を対象に、市場の多面的なレイヤーを通じた詳細な分析を提供しています。読者は、新たな動向、分野特有の課題、進化する競合情勢に関する包括的な考察を得ることができます。的を絞った調査と戦略的先見性の価値を強調する本分析は、技術投資と市場の需要を調和させることの重要性を強調しています。

診断と治療介入の境界線が曖昧になり続ける中、医療における精密さの必要性はかつてないほど高まっています。技術革新は患者の予後を改善するだけでなく、個々の患者の遺伝的・分子的プロファイルに合わせた個別化治療法の開発も促進しています。この入門的概要では、市場の変革的シフト、セグメンテーションのニュアンス、そしてこの急速に進化する業界における将来を見据えた戦略の骨格となる実用的な提言について、詳細に検討するための舞台を整えます。

精密診断・医療市場の変革

市場は、その基礎となる風景を再構築する変革的なシフトを経験しています。デジタルヘルス技術、人工知能、データ分析におけるかつてない進歩が、診断ツールとプラットフォームの進化を促しています。これらの技術は診断結果の精度を高めるだけでなく、患者情報のリアルタイム統合を可能にし、より正確でタイムリーな治療判断につながっています。

患者の安全性とデータプライバシーを確保しながらイノベーションをサポートするために、世界各地の規制枠組みが進化しています。このような規制の変化は、研究開発への投資拡大に拍車をかけ、ヘルスケアシステムのダイナミックなニーズに俊敏に対応する新しい診断薬プラットフォームの開発に拍車をかけています。さらに、ゲノミクス、分子診断学、プロテオミクスと日常臨床との融合が進むにつれ、市場の成長が加速し、従来の診断手法の見直しが促されています。

業界各社は、次世代シーケンシングや先進画像診断システムなどの技術に投資することで、この新しい環境に継続的に適応しています。こうした投資は、製品能力を新たな臨床ニーズに合致させるために不可欠です。市場の変革の軌跡は、技術革新と患者中心のケアとのダイナミックな相互作用を物語っており、医療サービスの提供に新たな基準を打ち立てつつあります。

市場成長のための主要セグメンテーション洞察

市場セグメンテーションを詳細に調べると、精密診断・医療分野の成長軌道を理解する上で極めて重要な複雑な層が見えてくる。製品別に見ると、市場は消耗品と機器に区分されます。消耗品はさらにキット、アッセイ、試薬に分類され、機器は分析装置、イメージングシステム、シーケンサーに分類されます。

技術ベースのセグメンテーションは分析にさらなる深みを与え、ゲノミクス、分子診断、プロテオミクスを通じて市場を特徴づける。分子診断の分野では、次世代シーケンシングとポリメラーゼ連鎖反応プロセスにさらなる改良が見られ、市場の革新的な勢いの多くを支えています。このような技術的な層別化は、最先端の進歩を際立たせるだけでなく、従来の手法からより高度な統合システムへの移行を強調するものでもあります。

アプリケーション別にセグメンテーションを行うと、疾病診断、精密治療、研究開発など、明確な市場ニッチが浮かび上がってくる。各用途分野はさらに細分化され、疾病診断では慢性疾患と遺伝性疾患、精密治療では個別化医療と標的治療に焦点が当てられます。さらに、エンドユーザーセグメントでは、臨床検査室（診断検査室と調査検査室を含む）と病院による利用を包括的に見ています。この多角的なセグメンテーションの枠組みは、利害関係者に市場の可能性と戦略的開拓の道筋に関する重要な洞察を提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延が世界的に増加
    • 世界中でパーソナライズされたヘルスケアソリューションの需要が増加
    • 世界中で精密診断を推進する政府の取り組み
  • 抑制要因
    • 精密診断と個別治療における厳格な規制遵守要件
  • 機会
    • バイオマーカーの発見と検証技術をサポートするバイオ医薬品調査の急増
    • ゲノム技術の進歩により個別治療計画が可能に
  • 課題
    • 精密診断技術を従来のヘルスケアシステムに統合する際の課題
• 市場セグメンテーション分析
  • 製品：正確な病気の検出とモニタリングのためのキットとアッセイの好感度が高まっています
  • 応用：精密診断と医療の精密治療への応用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 精密診断・医療市場：製品別

• 消耗品
  • キットとアッセイ
  • 試薬
• 機器
  • アナライザー
  • イメージングシステム
  • シーケンサー

第7章 精密診断・医療市場：技術別

• ゲノミクス
• 分子診断
  • 次世代シーケンシング
  • ポリメラーゼ連鎖反応
• プロテオミクス

第8章 精密診断・医療市場：用途別

• 病気の診断
  • 慢性疾患
  • 遺伝性疾患
• プレシジョン・セラピューティクス
  • パーソナライズ医療
  • 標的療法
• 研究開発

第9章 精密診断・医療市場：エンドユーザー別

• 臨床検査室
  • 診断検査室
  • 調査室
• 病院

第10章 南北アメリカの精密診断・医療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の精密診断・医療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの精密診断・医療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AstraZeneca PLC
• Baxter International Inc.
• Becton, Dickinson and Company
• Biogen Inc.
• Bristol-Myers Squibb Company
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• GE Healthcare Technologies, Inc.
• Illumina, Inc.
• International Business Machines Corp.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Lantheus Medical Imaging, Inc.
• Medtronic PLC
• Myriad Genetics Inc.
• Novartis AG
• OneOme, LLC
• Pfizer Inc.
• Qiagen NV
• Quest Diagnostics Incorporated
• Sanofi S.A.
• Siemens Healthineers
• Swiss Precision Diagnostics GmbH
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET MULTI-CURRENCY
• FIGURE 2. PRECISION DIAGNOSTICS & MEDICINE MARKET MULTI-LANGUAGE
• FIGURE 3. PRECISION DIAGNOSTICS & MEDICINE MARKET RESEARCH PROCESS
• FIGURE 4. PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. PRECISION DIAGNOSTICS & MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. PRECISION DIAGNOSTICS & MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PRECISION DIAGNOSTICS & MEDICINE MARKET DYNAMICS
• TABLE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 71. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 73. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 74. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 76. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 123. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 125. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 126. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 128. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 130. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 131. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 133. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 135. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 136. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 138. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 140. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 141. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 150. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 160. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 161. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 166. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 168. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 170. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 171. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 175. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 176. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 178. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 180. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 181. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 185. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 186. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 188. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 190. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 191. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 203. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 205. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 206. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 208. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 210. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 211. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 213. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 215. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 216. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 218. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 220. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 221. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 223. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 225. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 226. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 228. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 230. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 231. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 244. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 245. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 246. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 247. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 248. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 249. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 251. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 252. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 254. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 256. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 257. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 258. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 259. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 261. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 262. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 264. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 266. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 267. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 268. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 269. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 271. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 272. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 273. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 274. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 276. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 277. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 279. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 281. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 282. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 284. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 286. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 287. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 288. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 289. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 290. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 291. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 292. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 293. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 294. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 295. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 296. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 297. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 298. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 299. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 301. ISRAEL PRECISION DI

The Precision Diagnostics & Medicine Market was valued at USD 160.21 billion in 2024 and is projected to grow to USD 176.82 billion in 2025, with a CAGR of 11.00%, reaching USD 299.71 billion by 2030.

The precision diagnostics and medicine market is undergoing a period of unprecedented transformation, driven by rapid technological innovations, increasing healthcare demands, and a broader shift towards individualized patient care. In today's dynamic environment, diagnostic accuracy and early disease identification have become pivotal for effective treatment strategies. The convergence of multidisciplinary expertise-from biotechnology and data science to clinical innovation-has paved the way for breakthroughs that redefine how diseases are detected and managed.

This report provides an in-depth analysis aimed at guiding industry leaders, investors, and decision-makers through the multifaceted layers of the market. Within these pages, readers will find comprehensive insights into emerging trends, sector-specific challenges, and the evolving competitive landscape. Emphasizing the value of targeted research and strategic foresight, the analysis underscores the importance of harmonizing technological investments with market demands.

As the line between diagnostics and therapeutic interventions continues to blur, the need for precision in medicine has never been more critical. Innovations are not only improving patient outcomes but are also fostering the development of personalized treatment modalities tailored to the genetic and molecular profiles of individual patients. This introductory overview sets the stage for a detailed exploration of the market's transformative shifts, segmentation nuances, and actionable recommendations that form the backbone of a forward-looking strategy in this rapidly evolving industry.

Transformative Shifts in the Precision Diagnostics & Medicine Landscape

The market is experiencing transformative shifts that are reshaping its foundational landscape. Unprecedented advancements in digital health technologies, artificial intelligence, and data analytics are driving the evolution of diagnostic tools and platforms. These technologies are not only augmenting the accuracy of diagnostic results but are also enabling real-time integration of patient information, leading to more precise and timely treatment decisions.

Regulatory frameworks across global jurisdictions are evolving to support innovations while ensuring patient safety and data privacy. Such regulatory changes are spurring greater levels of investment in R&D, catalyzing the development of novel diagnostics platforms that are more agile and responsive to the dynamic needs of healthcare systems. Moreover, the increasing convergence of genomics, molecular diagnostics, and proteomics with everyday clinical practices is accelerating market growth and prompting a rethinking of conventional diagnostic methodologies.

Industry players are continuously adapting to this new environment by investing in next-generation sequencing and advanced imaging systems, among other technologies. These investments are essential to align product capabilities with emerging clinical needs. The market's transformative trajectory illustrates a dynamic interplay between technological innovation and patient-centric care that is setting a new standard in the delivery of health services.

Key Segmentation Insights for Market Growth

A granular examination of market segmentation reveals intricate layers that are pivotal for understanding growth trajectories in the precision diagnostics and medicine arena. When viewed through the lens of product, the market is delineated into consumables and instruments. Consumables have further been dissected into kits, assays, and reagents, while instruments are categorized into analyzers, imaging systems, and sequencers; each subgroup responds to unique operational demands and technological advancements.

Technology-based segmentation offers additional depth to the analysis, characterizing the market through genomics, molecular diagnostics, and proteomics. Within the sphere of molecular diagnostics, further refinement is seen in next-generation sequencing and polymerase chain reaction processes, which anchor much of the market's innovative momentum. This technological stratification not only highlights the cutting-edge advancements but also underscores the transition from traditional methodologies to more advanced, integrated systems.

When segmentation is approached by application, distinct market niches emerge such as disease diagnosis, precision therapeutics, and research and development. Each application area is further broken down to focus on chronic diseases and genetic disorders under disease diagnosis, and personalized medicine and targeted therapies within precision therapeutics. In addition, the end-user segment provides a comprehensive look at utilization by clinical laboratories-with diagnostic and research laboratories-and hospitals. This multidimensional segmentation framework offers stakeholders critical insight into market potentials and strategic avenues for targeted development.

Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Kits & Assays and Reagents. The Instruments is further studied across Analyzers, Imaging Systems, and Sequencers.

Based on Technology, market is studied across Genomics, Molecular Diagnostics, and Proteomics. The Molecular Diagnostics is further studied across Next-Generation Sequencing and Polymerase Chain Reaction.

Based on Application, market is studied across Disease Diagnosis, Precision Therapeutics, and Research & Development. The Disease Diagnosis is further studied across Chronic Diseases and Genetic Disorders. The Precision Therapeutics is further studied across Personalized Medicine and Targeted Therapies.

Based on End User, market is studied across Clinical Laboratories and Hospitals. The Clinical Laboratories is further studied across Diagnostic Laboratories and Research Laboratories.

Key Regional Insights in a Global Market

The geographic breakdown of the precision diagnostics and medicine market offers compelling insights into regional growth patterns and strategic priorities necessary to navigate a diverse global landscape. The Americas have long been a hotbed for innovation and capital investment, driven by robust healthcare infrastructures and advanced research ecosystems. Meanwhile, the region encompassing Europe, the Middle East, and Africa is witnessing rapid policy reforms and collaborative research initiatives that are fueling new opportunities in diagnostics and personalized medicine. Strategic partnerships in these regions are also expanding as public and private sectors align to address healthcare challenges.

Similarly, in the Asia-Pacific region, rapid economic growth combined with significant investments in healthcare infrastructure is driving market dynamism. Emerging economies in this region are experiencing a surge in the adoption of advanced diagnostic tools as governments bolster efforts towards healthcare modernization. The interplay between socio-economic advancements and technological health innovations is critical to understanding the regional developmental trajectories. Each of these regions presents unique regulatory, economic, and cultural factors which together shape the global dynamics of the market and offer varied opportunities for industry expansion.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation

A host of leading companies in the precision diagnostics and medicine space are playing pivotal roles in propelling market innovations forward. Influential players such as Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc. are laying the groundwork with their robust pipelines and strategic investments in next-generation diagnostics. Equally noteworthy are the contributions from Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, and Danaher Corporation, whose research and development efforts are shaping the future landscape of diagnostics and therapeutic interventions.

Global giants like F. Hoffmann-La Roche Ltd, GE Healthcare Technologies, Inc., and Illumina, Inc. continue to set benchmarks with their state-of-the-art technology and comprehensive service models. International Business Machines Corp., Johnson & Johnson Services, Inc., and Koninklijke Philips N.V. are making significant strides by blending clinical insights with technological innovation. Also contributing to this evolution are companies like Lantheus Medical Imaging, Inc., Medtronic PLC, Myriad Genetics Inc., and Novartis AG, all of which have capitalized on a combination of advanced research, strategic collaborations, and progressive market approaches. Innovators such as OneOme, LLC, Pfizer Inc., Qiagen NV, and Quest Diagnostics Incorporated are also vital components of this ecosystem, underscoring the competitive momentum. Leaders like Sanofi S.A., Siemens Healthineers, Swiss Precision Diagnostics GmbH, and Thermo Fisher Scientific Inc. further emphasize the strategic diversity and robust market positioning that define the future of this critical field.

The report delves into recent significant developments in the Precision Diagnostics & Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare Technologies, Inc., Illumina, Inc., International Business Machines Corp., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Medtronic PLC, Myriad Genetics Inc., Novartis AG, OneOme, LLC, Pfizer Inc., Qiagen NV, Quest Diagnostics Incorporated, Sanofi S.A., Siemens Healthineers, Swiss Precision Diagnostics GmbH, and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

To capitalize on the rapidly evolving landscape of precision diagnostics and medicine, industry leaders should consider a multi-pronged strategy that integrates innovation, strategic partnerships, and market diversification. It is imperative to increase investments in cutting-edge technologies, particularly in areas such as next-generation sequencing and imaging systems, to meet the growing demand for personalized diagnostics. Emphasizing collaborative research and development, especially across the boundaries of genomics, molecular diagnostics, and proteomics, will help accelerate product development cycles and enhance diagnostic accuracy.

A strong focus on regulatory compliance and proactive engagement with policy makers can yield significant competitive advantages. Leveraging emerging digital health tools to facilitate real-time data analytics and patient management can also streamline diagnostic workflows and improve clinical outcomes. Diversification within product and technology portfolios will allow companies to adapt quickly to market shifts and capitalize on emerging trends.

Furthermore, forging alliances with regional healthcare stakeholders can assist in tailoring products to localized needs, thereby strengthening market presence. Comprehensive market intelligence and scenario planning will be crucial in navigating the complexities of global markets while ensuring resilience in the face of disruptive innovations. These recommendations provide a strategic roadmap for leaders aiming to drive sustained growth and operational excellence in this fast-paced environment.

Conclusion: Driving Future Growth

The analysis underscores that precision diagnostics and medicine is positioned at the crossroads of transformation fueled by technological innovation and an unwavering commitment to patient-centricity. Recognizing the full potential of this market requires a deep understanding of its segmented structure, regional dynamics, and innovative company strategies. These insights are critical for developing robust strategies that not only respond to current market demands but also anticipate future trends.

This comprehensive examination highlights the momentum behind the integration of cutting-edge technologies with traditional diagnostic methods, thereby enabling substantial improvements in healthcare delivery. With strategic investment in research and development, proactive regulatory navigation, and a keen focus on market-specific nuances, industry leaders can unlock significant value. The convergence of diverse yet complementary factors is paving the way for a new era where precision diagnostics and medicine will play a central role in shaping global health outcomes. The path forward is clear: embracing innovation while remaining agile will be pivotal for achieving long-term success.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases globally
    • 5.1.1.2. Increasing demand for personalized healthcare solutions worldwide
    • 5.1.1.3. Government initiatives promoting precision diagnostics worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory compliance requirements in precision diagnostics and personalized treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Surge in biopharmaceutical research supporting biomarker discovery and validation techniques
    • 5.1.3.2. Advancements in genomic technologies enabling personalized treatment plans
  • 5.1.4. Challenges
    • 5.1.4.1. Issues in integrating precision diagnostic techniques into legacy healthcare systems
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for kits & assays for precise disease detection and monitoring
  • 5.2.2. Application: Expanding application of precision diagnostics and medicine in precision therapeutics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Precision Diagnostics & Medicine Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Kits & Assays
  • 6.2.2. Reagents
• 6.3. Instruments
  • 6.3.1. Analyzers
  • 6.3.2. Imaging Systems
  • 6.3.3. Sequencers

7. Precision Diagnostics & Medicine Market, by Technology

• 7.1. Introduction
• 7.2. Genomics
• 7.3. Molecular Diagnostics
  • 7.3.1. Next-Generation Sequencing
  • 7.3.2. Polymerase Chain Reaction
• 7.4. Proteomics

8. Precision Diagnostics & Medicine Market, by Application

• 8.1. Introduction
• 8.2. Disease Diagnosis
  • 8.2.1. Chronic Diseases
  • 8.2.2. Genetic Disorders
• 8.3. Precision Therapeutics
  • 8.3.1. Personalized Medicine
  • 8.3.2. Targeted Therapies
• 8.4. Research & Development

9. Precision Diagnostics & Medicine Market, by End User

• 9.1. Introduction
• 9.2. Clinical Laboratories
  • 9.2.1. Diagnostic Laboratories
  • 9.2.2. Research Laboratories
• 9.3. Hospitals

10. Americas Precision Diagnostics & Medicine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Precision Diagnostics & Medicine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Precision Diagnostics & Medicine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Precision Diagnostics announces the launch of VerifID, a solution that redefines sample authentication
  • 13.3.2. Aignostics accelerates precision diagnostics with a USD 34 million Series B funding for AI-driven pathology
  • 13.3.3. Danaher Corporation announced the launch of two new CLIA and CAP-certified labs
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca PLC
• 3. Baxter International Inc.
• 4. Becton, Dickinson and Company
• 5. Biogen Inc.
• 6. Bristol-Myers Squibb Company
• 7. Danaher Corporation
• 8. F. Hoffmann-La Roche Ltd
• 9. GE Healthcare Technologies, Inc.
• 10. Illumina, Inc.
• 11. International Business Machines Corp.
• 12. Johnson & Johnson Services, Inc.
• 13. Koninklijke Philips N.V.
• 14. Lantheus Medical Imaging, Inc.
• 15. Medtronic PLC
• 16. Myriad Genetics Inc.
• 17. Novartis AG
• 18. OneOme, LLC
• 19. Pfizer Inc.
• 20. Qiagen NV
• 21. Quest Diagnostics Incorporated
• 22. Sanofi S.A.
• 23. Siemens Healthineers
• 24. Swiss Precision Diagnostics GmbH
• 25. Thermo Fisher Scientific Inc.